Ranibizumab - CaLiGraph

Property	Value
rdf:type	Genentech brand Hoffmann-La Roche brand owl:NamedIndividual Novartis brand Orphan drug Therapeutic monoclonal antibody Largest selling pharmaceutical product Ophthalmology drug Monoclonal antibody for tumors Drug granted breakthrough therapy designation
rdfs:label	Ranibizumab
owl:sameAs	dbr:Ranibizumab
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Category:Ophthalmology_drugs http://en.wikipedia.org/wiki/List_of_largest_selling_pharmaceutical_products http://en.wikipedia.org/wiki/Roche http://en.wikipedia.org/wiki/Genentech http://en.wikipedia.org/wiki/Monoclonal_antibody http://en.wikipedia.org/wiki/Category:Orphan_drugs http://en.wikipedia.org/wiki/List_of_drugs:_R%E2%80%93Rb http://en.wikipedia.org/wiki/List_of_therapeutic_monoclonal_antibodies http://en.wikipedia.org/wiki/Anti%E2%80%93vascular_endothelial_growth_factor_therapy http://en.wikipedia.org/wiki/Protein_kinase_inhibitor http://en.wikipedia.org/wiki/Category:Monoclonal_antibodies http://en.wikipedia.org/wiki/Category:Novartis_brands http://en.wikipedia.org/wiki/Monoclonal_antibody_therapy http://en.wikipedia.org/wiki/Novartis http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation http://en.wikipedia.org/wiki/Category:Genentech_brands http://en.wikipedia.org/wiki/Category:Hoffmann-La_Roche_brands http://en.wikipedia.org/wiki/Biosimilar
skos:prefLabel	Ranibizumab
skos:altLabel	Lucentis ranibizumab ranibizumab (Lucentis)
clgo:alternativeName	Lucentis, Byooviz, Susvimo, others
clgo:casNumber	347396-82-1
clgo:chEMBL	1201825
clgo:drugbank	DB01270
clgo:fdaUniiCode	ZL1R02VT79
clgo:kegg	D05697
clgo:medlinePlus	a607044
is clgo:product of	Genentech

About: clgr:Ranibizumab